Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kadmon, D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sukin, SW; Chhikara, M; Zhu, XH; Ayala, G; Aguilar, LK; Smith, EO; Miles, BJ; Thompson, TC; Kadmon, D; Aguilar-Cordova, E
      In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer

      MOLECULAR THERAPY
    2. Miles, BJ; Shalev, M; Aguilar-Cordova, E; Timme, TL; Lee, HM; Yang, G; Adler, HL; Kernen, K; Pramudji, CK; Satoh, T; Gdor, Y; Ren, CZ; Ayala, G; Wheeler, TM; Butler, EB; Kadmon, D; Thompson, TC
      Prostate-specific antigen response and systemic T cell activation after insitu gene therapy in prostate cancer patients failing radiotherapy

      HUMAN GENE THERAPY
    3. Teh, BS; Aguilar-Cordova, E; Kernen, K; Chou, CC; Shalev, M; Vlachaki, MT; Miles, B; Kadmon, D; Mai, WY; Caillouet, J; Davis, M; Ayala, G; Wheeler, T; Brady, J; Carpenter, LS; Lu, HH; Chiu, JK; Woo, SY; Thompson, T; Butler, EB
      Phase I/II trial evaluating combined radiotherapy and in situ gene therapywith or without hormonal therapy in the treatment of prostate cancer - A preliminary report

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    4. Shaker, MR; Yang, G; Timme, TL; Park, SH; Kadmon, D; Ren, CZ; Ji, XR; Lee, HM; Sehgal, I; Anzano, M; Sporn, MB; Thompson, TC
      Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

      CLINICAL & EXPERIMENTAL METASTASIS
    5. Kim, ED; Scardino, PT; Kadmon, D; Slawin, K; Nath, RK
      Interposition sural nerve crafting during radical retropubic prostatectomy

      UROLOGY
    6. Shalev, M; Thompson, TC; Kadmon, D; Ayala, G; Kernen, K; Miles, BJ
      Gene therapy for prostate cancer

      UROLOGY
    7. Kim, ED; Nath, R; Kadmon, D; Lipshultz, LI; Miles, BJ; Slawin, KM; Tang, HY; Wheeler, T; Scardino, PT
      Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup

      JOURNAL OF UROLOGY
    8. Gore, JL; Shariat, SF; Miles, BJ; Kadmon, D; Jiang, N; Wheeler, TM; Slawin, KM
      Optimal combinations of systematic sextant and laterally directed biopsiesfor detection of prostate cancer

      JOURNAL OF UROLOGY
    9. Shalev, M; Thompson, TC; Frolov, A; Lippman, SM; Hong, WK; Fritsche, H; Kadmon, D
      Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy

      CLINICAL CANCER RESEARCH
    10. Thaller, C; Shalev, M; Frolov, A; Eichele, G; Thompson, TC; Williams, RH; Dillioglugil, O; Kadmon, D
      Fenretinide therapy in prostate cancer: Effects on tissue and serum retinoid concentration

      JOURNAL OF CLINICAL ONCOLOGY
    11. Lotan, Y; Xu, XC; Shalev, M; Lotan, R; Williams, R; Wheeler, TM; Thompson, TC; Kadmon, D
      Differential expression of nuclear retinoid receptors in normal and malignant prostates

      JOURNAL OF CLINICAL ONCOLOGY
    12. Shalev, M; Miles, BJ; Thompson, TC; Ayala, G; Butler, EB; Aguilar-Cordova, E; Kadmon, D
      Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene

      WORLD JOURNAL OF UROLOGY
    13. Ayala, G; Wheeler, TM; Shalev, M; Thompson, TC; Miles, B; Aguilar-Cordova, E; Chakraborty, S; Kadmon, D
      Cytopathic effect of in situ gene therapy in prostate cancer

      HUMAN PATHOLOGY
    14. Shalev, M; Kadmon, D; Teh, BS; Butler, EB; Aguilar-Cordova, E; Thompson, TC; Herman, JR; Adler, HL; Scardino, PT; Miles, BJ
      Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer

      JOURNAL OF UROLOGY
    15. Kadmon, D
      Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate - Comment

      JOURNAL OF UROLOGY
    16. Kadmon, D
      Editorial: Beyond prostate specific antigen-markers for prostate cancer for the 21st century

      JOURNAL OF UROLOGY
    17. Smith, VC; Edwards, RA; Jorgensen, JL; Goldfarb, RA; Kadmon, D; Cagle, P; Truong, LD
      Unilocular retroperitoneal cyst of mesothelial origin presenting as a renal mass - A report of 2 cases

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    18. Smith, CP; Sharma, A; Ayala, G; Cagle, P; Kadmon, D
      Solitary pulmonary metastasis from prostate cancer

      JOURNAL OF UROLOGY
    19. ANDRIOLE GL; GUESS HA; EPSTEIN JI; WISE H; KADMON D; CRAWFORD ED; HUDSON P; JACKSON CL; ROMAS NA; PATTERSON L; COOK TJ; WALDSTREICHER J
      TREATMENT WITH FINASTERIDE PRESERVES USEFULNESS OF PROSTATE-SPECIFIC ANTIGEN IN THE DETECTION OF PROSTATE-CANCER - RESULTS OF A RANDOMIZED,DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL

      Urology
    20. WALSH P; EPSTEIN J; PATTERSON L; WISE H; KADMON D; CRAWFORD D; JACKSON C; COOK T; PAPPAS F; WALDSTREICHER J
      SIMILAR DETECTION OF PROSTATE-CANCER BY SERIAL BIOPSIES IN MEN WITH ELEVATED PSA LEVELS ON FINASTERIDE AND PLACEBO - RESULTS OF A 4-YEAR PROSPECTIVE-STUDY

      The Journal of urology
    21. LEIS PF; STEVENS KR; BAER SC; KADMON D; GOLDBERG LH; WANG XJ
      A C-RAS(HA) MUTATION IN THE METASTASIS OF A HUMAN-PAPILLOMAVIRUS (HPV)-18 POSITIVE PENILE SQUAMOUS-CELL CARCINOMA SUGGESTS A COOPERATIVE EFFECT BETWEEN HPV-18 AND C-RAS(HA) ACTIVATION IN MALIGNANT PROGRESSION

      Cancer
    22. SUTTON MA; WATKINS HL; GREEN LK; KADMON D
      INTRACRANIAL METASTASES AS THE FIRST MANIFESTATION OF PROSTATE-CANCER

      Urology
    23. TIMME TL; YANG GA; ROGERS E; KADMON D; MORGANSTERN JP; PARK SH; THOMPSON TC
      RETROVIRAL TRANSDUCTION OF TRANSFORMING GROWTH-FACTOR-BETA-1 INDUCES PLEIOTROPIC BENIGN PROSTATIC GROWTH ABNORMALITIES IN MOUSE PROSTATE RECONSTITUTIONS

      Laboratory investigation
    24. KADMON D; WEINBERG AD; WILLIAMS RH; PAVLIK VN; COOPER P; MIGLIORE PJ
      PITFALLS IN INTERPRETING PROSTATE-SPECIFIC ANTIGEN VELOCITY

      The Journal of urology
    25. TIMME TL; TRUONG LD; SLAWIN KM; KADMON D; PARK SH; THOMPSON TC
      MESENCHYMAL EPITHELIAL INTERACTIONS AND TRANSFORMING GROWTH-FACTOR-BETA-1 EXPRESSION DURING NORMAL AND ABNORMAL PROSTATIC GROWTH

      Microscopy research and technique
    26. THOMPSON TC; PARK SH; TIMME TL; REN C; EASTHAM JA; DONEHOWER LA; BRADLEY A; KADMON D; YANG G
      LOSS OF P53 FUNCTION LEADS TO METASTASIS IN RAS-INITIATED MOUSE PROSTATE-CANCER(MYC)

      Oncogene
    27. TIMME TL; EASTHAM JA; PARK SH; REN C; KADMON D; DONEHOWER LA; BRADLEY A; THOMPSON TC
      P53 GENE LOSS AND ALTERATION DURING PROSTATE-CANCER PROGRESSION AND METASTASIS IN A NOVEL MOUSE MODEL - RELEVANCE TO HUMAN PROSTATE-CANCER

      Journal of cellular biochemistry
    28. TIMME TL; YANG G; TRUONG LD; KADMON D; PARK SH; THOMPSON TC
      TRANSFORMING GROWTH-FACTOR-BETA LOCALIZATION DURING MOUSE PROSTATE MORPHOGENESIS AND IN PROSTATIC GROWTH ABNORMALITIES

      World journal of urology
    29. ANDRIOLE G; LIEBER M; SMITH J; SOLOWAY M; SCHROEDER F; KADMON D; DEKERNION J; RAJFER J; BOAKE R; CRAWFORD D; RAMSEY E; PERREAULT J; TRACHTENBERG J; FRADET T; BLOCK N; MIDDLETON R; NG J; FERGUSON D; GORMLEY G
      TREATMENT WITH FINASTERIDE FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE-CANCER

      Urology
    30. THOMPSON TC; TIMME TL; PARK SH; REN C; BALEY PA; EASTHAM JA; SEHGAL I; YANG G; KADMON D
      TISSUE AND CELL-CELL INTERACTIONS IN PROSTATE-CANCER PROGRESSION

      Cancer
    31. THOMPSON TC; TIMME TL; PARK SH; REN C; BALEY PA; DONEHOWER LA; KADMON D
      A ROLE FOR P53 IN PROSTATE-CANCER METASTASIS IN THE MOUSE PROSTATE RECONSTITUTION MODEL SYSTEM

      Journal of cellular biochemistry
    32. EASTHAM JA; PARK SH; REN C; TIMME TL; BALEY PA; KADMON D; DONEHOWER LA; SCARDINO PT; THOMPSON TC
      THE USE OF A NOVEL MOUSE MODEL FOR PROSTATE-CANCER METASTASIS TO DETERMINE ALTERATIONS IN GENE-EXPRESSION IN THE METASTATIC PHENOTYPE

      Journal of cellular biochemistry
    33. SLAWIN K; KADMON D; PARK SH; SCARDINO PT; ANZANO M; SPORN MB; THOMPSON TC
      FENRETINIDE SELECTS FOR ALTERNATIVE PATHWAYS OF CARCINOGENESIS IN THEMOUSE PROSTATE RECONSTITUTION (MPR) MODEL SYSTEM

      Journal of cellular biochemistry
    34. FEENEY D; QUESADA ET; SIRBASKU DM; KADMON D
      TRANSITIONAL-CELL CARCINOMA IN A TUBERCULOUS KIDNEY - CASE-REPORT ANDREVIEW OF THE LITERATURE - REPLY

      The Journal of urology
    35. FEENEY D; QUESADA ET; SIRBASKU DM; KADMON D
      TRANSITIONAL-CELL CARCINOMA IN A TUBERCULOUS KIDNEY - CASE-REPORT ANDREVIEW OF THE LITERATURE

      The Journal of urology
    36. TIMME TL; TRUONG LD; MERZ VW; KREBS T; KADMON D; FLANDERS KC; PARK SH; THOMPSON TC
      MESENCHYMAL-EPITHELIAL INTERACTIONS AND TRANSFORMING GROWTH-FACTOR-BETA EXPRESSION DURING MOUSE PROSTATE MORPHOGENESIS

      Endocrinology
    37. THOMPSON TC; KADMON D; PARK SH; EGAWA S; YOSHIDA K; TIMME TL
      GENETIC PREDISPOSITION AND MESENCHYMAL-EPITHELIAL INTERACTIONS IN RASPLUS MYC INDUCED CARCINOGENESIS IN RECONSTITUTED MOUSE PROSTATE

      Molecular carcinogenesis
    38. SLAWIN K; KADMON D; PARK SH; SCARDINO PT; ANZANO M; SPORN MB; THOMPSON TC
      DIETARY FENRETINIDE, A SYNTHETIC RETINOID, DECREASES THE TUMOR-INCIDENCE AND THE TUMOR MASS OF RAS-INDUCED CARCINOMAS IN THE MOUSE PROSTATERECONSTITUTION MODEL SYSTEM(MYC)

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 20:21:14